Has John Bendo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $126,634 in general payments to John Bendo, MD across 21 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Bendo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Bendo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Bendo, MD

Orthopaedic Surgery of the Spine · New York, NYNPI 1649258120

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $124,980 of the $126,634 with a category attached, or 98.7%. Altus Partners. LLC accounts for 99.5% of it on its own, with 6 other manufacturers making up the rest.

$126,634in general payments, 2019–2025

Across 21 payments — averaging $6030.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Altus Partners. LLC$126K
Zimmer Biomet$230
Stryker$149
Globus Medical$91
KCI USA, Inc.$75
Johnson & Johnson$56
plus $53 from 1 others

What the payments were for

Royalty or licence$124,98099%
Consulting fees$1,0001%
Food & beverage$6541%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Altus Partners. LLC	13	$125,980
Zimmer Biomet	2	$230
Stryker	1	$149
Globus Medical	2	$91
KCI USA, Inc.	1	$75
Johnson & Johnson	1	$56
Sanara Medtech Inc.	1	$53

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$126,634 in reported general payments places this provider in the 85th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York →

Medicare billing

Part B allowed, 2024

$283,029

Medicare patients

422

Services billed

782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	66	$405
Meloxicam	13	$51
Prednisone	20	$48

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in New York

Frank SchwabNew York$5.1M
Han KimNew York$3.9M
Todd AlbertNew York$2.7M
Jeffrey SpivakNew York$1.3M
Aaron BucklandNew York$1M
Sheeraz QureshiNew York$828K
Jeffrey GoldsteinNew York$765K
Fabien BitanNew York$624K
Oheneba Boachie-AdjeiNew York$313K
Harvinder SandhuNew York$266K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →